Granite Point Capital — Full Portfolio
4 tracked investments · listed companies and verified rows first
Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.
BiotechHealthtechMendham, US
Gregory Mayes(Executive Officer, Director)Douglas Mayers(Executive Officer)inTamra Adams(Executive Officer)inAbel De La Rosa(Director)
BoardIyona Rajkomar(Director)inBenjamin Rovinski(Director)
Co-investorsAisling CapitalAltium CapitalAvego BioScience CapitalPontifax Venture CapitalAmzak HealthDelos Capital+8 more
Teikametrics offers an AI-powered marketplace intelligence platform for brands selling on Amazon, Walmart, and TikTok Shop, covering multi-marketplace campaign management, full-funnel advertising, generative-AI listing optimization, and analytics.
AdTechAI & Machine LearningE-commerceRetail TechBoston, US
Alasdair McLean-Foreman(Executive Officer, Director, Promoter)inSrinivas Guddanti(Executive Officer)Michael McMahon(Director)John Traugott(Director)Austin Westerling(Director)
Co-investorsCentana Growth PartnersIntel CapitalProgress VenturesJump Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.